Crescent Biopharma Announces First Patient Dosed In ASCEND Global Phase 1/2 Clinical Trial For Tumor Medication

Crescent Biopharma +6.53%

Crescent Biopharma

CBIO

12.07

+6.53%

Crescent Biopharma Announces First Patient Dosed In ASCEND Global Phase 1/2 Clinical Trial For Tumor Medication
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via